# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2015

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2016-02-24
- Accepted by EDGAR: Feb 24, 2016, 13:37 ET
- Period: 2015-12-31
- Accession: 0001047469-16-010364
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000104746916010364/a2227417z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000104746916010364/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2015-01-01 to 2015-12-31 | $11.41bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2015-01-01 to 2015-12-31 | $5.33bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2015-01-01 to 2015-12-31 | $140.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2015-01-01 to 2015-12-31 | $2.90bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2015-01-01 to 2015-12-31 | $2.33bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2015-01-01 to 2015-12-31 | $508.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2015-01-01 to 2015-12-31 | $622.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2015-01-01 to 2015-12-31 | $1.03bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2015-01-01 to 2015-12-31 | $3.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2015-01-01 to 2015-12-31 | $3.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2015-01-01 to 2015-12-31 | 304,920,035 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2015-01-01 to 2015-12-31 | $1.96bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2015-01-01 to 2015-12-31 | $952.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2015-01-01 to 2015-12-31 | −$263.2m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2015-12-31 | $549.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-12-31 | $6.98bn | us-gaap:AssetsCurrent |
| Total assets | at 2015-12-31 | $25.53bn | us-gaap:Assets |
| Current liabilities | at 2015-12-31 | $4.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-12-31 | $14.01bn | us-gaap:Liabilities |
| Long-term debt | at 2015-12-31 | $7.85bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2015-12-31 | $128.3m | us-gaap:DebtCurrent |
| Short-term borrowings | at 2015-12-31 | $109.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2015-12-31 | $9.89bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2015-12-31 | 305,314,120 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000104746916010364/a2227417z20-f.htm

Filed Feb 24, 2016.
Source: SEC EDGAR, the filing index for accession 0001047469-16-010364. Last ingested by Listed: Nov 3, 2026, 10:24 ET. No prices; not investment advice.